Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Pancreatic Cancer
- Gastrointestinal Cancer
- Gynecological Cancers
- Surgical Oncology
- Urological Cancers
- Adjuvant Therapy
- Brain and Spinal Cord Cancer
- Leukemia
Abstract
Citation: Clin Oncol. 2020;5(1):1712.DOI: 10.25107/2474-1663.1712
Total Pancreatectomy with Spleen Preservation for Distal Cholangiocarcinoma Synchronous with Multifocal IPMNs and a Neuroendocrine Tumour of the Pancreas
Abdelhak Lamara, Badreddine Nini, Mohamed Boukhane1, Sid Ahmed Medjahdi, Amel Soualmia, Abdelkrim Rehamnia, Nacereddine Lemaici and Saliha Benyarbah
Department of General Surgery, Regional Military University Hospital of Constantine, Algeria National Transplant Coordination, Algeria Department of Gastroenterology, Regional Military University Hospital of Constantine, Algeria Department of Pathology, Regional Military University Hospital of Constantine, Algeria
*Correspondance to: Abdelhak Lamara
PDF Full Text Case Report | Open Access
Abstract:
Introduction: Total pancreatectomy is the treatment of choice for multiple tumor locations in the pancreas, especially when it comes to the multifocal association of different lesions. Case Presentation: We report the case of a 62-year-old woman who underwent a complete pancreatectomy with spleen preservation for distal cholangiocarcinoma synchronous with multifocal IPMNs and a neuroendocrine tumor of the pancreas. Discussion: In the presence of a diffuse disease of the pancreas and/or in the case of tumor association, total pancreatectomy remains the only valid oncological option. Conclusion: Total pancreatectomy can be performed safely and without added risk in the presence of multiple or multifocal lesions of the pancreas.
Keywords:
Total pancreatectomy; Multifocal lesions; TIPMN; Distal cholangiocarcinoma
Cite the Article:
Lamara A, Nini B, Boukhane M, Ahmed Medjahdi S, Soualmia A, Rehamnia A, et al. Total Pancreatectomy with Spleen Preservation for Distal Cholangiocarcinoma Synchronous with Multifocal IPMNs and a Neuroendocrine Tumour of the Pancreas. Clin Oncol. 2020; 5: 1712.